1. Home
  2. AREN vs CTSO Comparison

AREN vs CTSO Comparison

Compare AREN & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • CTSO
  • Stock Information
  • Founded
  • AREN 2016
  • CTSO 1997
  • Country
  • AREN United States
  • CTSO United States
  • Employees
  • AREN N/A
  • CTSO N/A
  • Industry
  • AREN Medical/Dental Instruments
  • CTSO Medical/Dental Instruments
  • Sector
  • AREN Health Care
  • CTSO Health Care
  • Exchange
  • AREN Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • AREN 64.1M
  • CTSO 61.3M
  • IPO Year
  • AREN N/A
  • CTSO N/A
  • Fundamental
  • Price
  • AREN $1.84
  • CTSO $1.00
  • Analyst Decision
  • AREN
  • CTSO Strong Buy
  • Analyst Count
  • AREN 0
  • CTSO 3
  • Target Price
  • AREN N/A
  • CTSO $4.67
  • AVG Volume (30 Days)
  • AREN 28.2K
  • CTSO 85.7K
  • Earning Date
  • AREN 05-16-2025
  • CTSO 05-08-2025
  • Dividend Yield
  • AREN N/A
  • CTSO N/A
  • EPS Growth
  • AREN N/A
  • CTSO N/A
  • EPS
  • AREN N/A
  • CTSO N/A
  • Revenue
  • AREN $234,396,000.00
  • CTSO $35,594,520.00
  • Revenue This Year
  • AREN $12.73
  • CTSO $24.50
  • Revenue Next Year
  • AREN $71.95
  • CTSO $21.77
  • P/E Ratio
  • AREN N/A
  • CTSO N/A
  • Revenue Growth
  • AREN 45.45
  • CTSO 14.51
  • 52 Week Low
  • AREN $0.56
  • CTSO $0.70
  • 52 Week High
  • AREN $2.18
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • AREN 65.73
  • CTSO 44.01
  • Support Level
  • AREN $1.46
  • CTSO $0.97
  • Resistance Level
  • AREN $1.72
  • CTSO $1.08
  • Average True Range (ATR)
  • AREN 0.12
  • CTSO 0.07
  • MACD
  • AREN 0.02
  • CTSO -0.01
  • Stochastic Oscillator
  • AREN 93.23
  • CTSO 17.53

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: